Cytotoxicity of propofol in human induced pluripotent stem cell-derived cardiomyocytes

被引：0
|
作者：
Koji Kido
Hiroyuki Ito
Yudai Yamamoto
Koshi Makita
Tokujiro Uchida
机构：
[1] Tokyo Medical and Dental University,Department of Anesthesiology
[2] Graduate School of Medical and Dental Sciences,Division of Anesthesia
[3] Kyoundo Hospital,undefined
来源：
Journal of Anesthesia | 2018年 / 32卷
关键词：
Propofol; Cardiomyocytes; Cytotoxicity; Induced pluripotent stem cells; Mitochondrial dysfunction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：120 / 131
页数：11
相关论文
共 50 条
  • [31] Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Zhao, Zhihan
    Lan, Huan
    El-Battrawy, Ibrahim
    Li, Xin
    Buljubasic, Fanis
    Sattler, Katherine
    Yuecel, Goekhan
    Lang, Siegfried
    Tiburcy, Malte
    Zimmermann, Wolfram-Hubertus
    Cyganek, Lukas
    Utikal, Jochen
    Wieland, Thomas
    Borggrefe, Martin
    Zhou, Xiao-Bo
    Akin, Ibrahim
    [J]. STEM CELLS INTERNATIONAL, 2018, 2018
  • [32] Human-induced pluripotent stem cell-derived cardiomyocytes: phenotypic and functional variability
    Koivumaki, J.
    Nikolay, N.
    Tuomainen, T.
    Takalo, J.
    Tavi, P.
    [J]. ACTA PHYSIOLOGICA, 2017, 219 : 4 - 4
  • [33] Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Lee, Sujeong
    Lee, Hyang-Ae
    Choi, Sung Woo
    Kim, Sung Joon
    Kim, Ki-Suk
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 296 : 42 - 53
  • [34] Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes
    Yamazaki, Daiju
    Kitaguchi, Takashi
    Ishimura, Masakazu
    Taniguchi, Tomohiko
    Yamanishi, Atsuhiro
    Saji, Daisuke
    Takahashi, Etsushi
    Oguchi, Masao
    Moriyama, Yuta
    Maeda, Sanae
    Miyamoto, Kaori
    Morimura, Kaoru
    Ohnaka, Hiroki
    Tashibu, Hiroyuki
    Sekino, Yuko
    Miyamoto, Norimasa
    Kanda, Yasunari
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2018, 136 (04) : 249 - 256
  • [35] Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes
    Cyganek, Lukas
    Tiburcy, Malte
    Sekeres, Karolina
    Gerstenberg, Kathleen
    Bohnenberger, Hanibal
    Lenz, Christof
    Henze, Sarah
    Stauske, Michael
    Salinas, Gabriela
    Zimmermann, Wolfram-Hubertus
    Hasenfuss, Gerd
    Guan, Kaomei
    [J]. JCI INSIGHT, 2018, 3 (12):
  • [36] The Effect of Fatty Acid on the Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Horikoshi, Yuichi
    Bai, Xiaowen
    Yan, Yasheng
    Terashvili, Maia
    Kwok, Wai-Meng
    Fujita, Satoshi
    Bosnjak, Zeljko
    [J]. CIRCULATION, 2017, 136
  • [37] QUANTITATIVE CONTRACTILE CHARACTERISTICS OF HUMAN EMBRYONIC AND INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
    Lundy, S.
    Regnier, M.
    Laflamme, M.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (01) : 115 - 115
  • [38] Hippo signalling modulates survival of human induced pluripotent stem cell-derived cardiomyocytes
    Foldes, G.
    Hellen, N.
    Vittay, O.
    Harding, S. E.
    [J]. CARDIOVASCULAR RESEARCH, 2016, 111 : S92 - S93
  • [39] Pharmacoelectrophysiology of Viral-Free Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes
    Mehta, Ashish
    Chung, YingYing
    Sequiera, Glen Lester
    Wong, Philip
    Liew, Reginald
    Shim, Winston
    [J]. TOXICOLOGICAL SCIENCES, 2013, 131 (02) : 458 - 469
  • [40] Evaluation of Genetic Stability of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Cell Therapy
    Yun, Jun Ho
    Seong, Dabin
    Kim, Yong Guk
    Kim, Hyunju
    Kim, Ji-Hye
    Park, Ki Dae
    Lee, Su-Hae
    Park, Misun
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 179 - 180
12345